Literature DB >> 25326562

Recovery of chylous pulmonary congestion in tuberous sclerosis complex-associated lymphangioleiomyomatosis.

Yoshiaki Kinoshita1, Atsuhiko Sakamoto1, Kouko Hidaka1.   

Abstract

Chyloptysis and chylous pulmonary congestion are extremely rare complications of lymphangioleiomyomatosis (LAM). We report a case of a 50-year-old woman with tuberous sclerosis complex-associated LAM, who presented with expectorating milky-white bronchial casts. She was diagnosed with chyloptysis and chylous pulmonary congestion by sputum analysis. Her symptoms and lung infiltration were improved by oral sirolimus therapy; moreover, serum Krebs von den Lungen-6 (KL-6) levels paralleled the symptoms and lung infiltration of these complications. We suggest that serum KL-6 may be a useful monitoring biomarker of chyloptysis and chylous pulmonary congestion in LAM. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25326562      PMCID: PMC4202066          DOI: 10.1136/bcr-2014-205701

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Immunohistochemical localisation of surfactant proteins A and D, and KL-6 in pulmonary alveolar proteinosis.

Authors:  Yuji Ohtsuki; Makoto Kobayashi; Seiji Yoshida; Nobuhito Kishimoto; Katsuhito Kubo; Akihito Yokoyama; Gang-Hong Lee; Mutsuo Furihata
Journal:  Pathology       Date:  2008-08       Impact factor: 5.306

2.  Resolution of chylous pulmonary congestion and respiratory failure in lymphangioleiomyomatosis with sirolimus therapy.

Authors:  Teng Moua; Eric J Olson; Hope C St Jean; Jay H Ryu
Journal:  Am J Respir Crit Care Med       Date:  2012-08-15       Impact factor: 21.405

3.  Sirolimus for lymphangioleiomyomatosis lesions.

Authors:  Jim J Egan; Kaspar Friedrich Remund; Paul Corris
Journal:  N Engl J Med       Date:  2008-05-01       Impact factor: 91.245

4.  Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis.

Authors:  Y Inoue; E Barker; E Daniloff; N Kohno; K Hiwada; L S Newman
Journal:  Am J Respir Crit Care Med       Date:  1997-07       Impact factor: 21.405

5.  Efficacy and safety of sirolimus in lymphangioleiomyomatosis.

Authors:  Francis X McCormack; Yoshikazu Inoue; Joel Moss; Lianne G Singer; Charlie Strange; Koh Nakata; Alan F Barker; Jeffrey T Chapman; Mark L Brantly; James M Stocks; Kevin K Brown; Joseph P Lynch; Hilary J Goldberg; Lisa R Young; Brent W Kinder; Gregory P Downey; Eugene J Sullivan; Thomas V Colby; Roy T McKay; Marsha M Cohen; Leslie Korbee; Angelo M Taveira-DaSilva; Hye-Seung Lee; Jeffrey P Krischer; Bruce C Trapnell
Journal:  N Engl J Med       Date:  2011-03-16       Impact factor: 91.245

6.  Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus.

Authors:  Angelo M Taveira-DaSilva; Olanda Hathaway; Mario Stylianou; Joel Moss
Journal:  Ann Intern Med       Date:  2011-06-21       Impact factor: 25.391

7.  KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease.

Authors:  N Kohno; Y Awaya; T Oyama; M Yamakido; M Akiyama; Y Inoue; A Yokoyama; H Hamada; S Fujioka; K Hiwada
Journal:  Am Rev Respir Dis       Date:  1993-09

8.  Chyloptysis in adults: presentation, recognition, and differential diagnosis.

Authors:  Kaiser G Lim; Edward C Rosenow; Bruce Staats; Christian Couture; Timothy I Morgenthaler
Journal:  Chest       Date:  2004-01       Impact factor: 9.410

Review 9.  Lymphangioleiomyomatosis: a clinical update.

Authors:  Francis X McCormack
Journal:  Chest       Date:  2008-02       Impact factor: 9.410

10.  Ageing and long-term smoking affects KL-6 levels in the lung, induced sputum and plasma.

Authors:  Nobuhisa Ishikawa; Witold Mazur; Tuula Toljamo; Katri Vuopala; Mikko Rönty; Yasushi Horimasu; Nobuoki Kohno; Vuokko L Kinnula
Journal:  BMC Pulm Med       Date:  2011-05-11       Impact factor: 3.317

View more
  1 in total

Review 1.  Chyloptysis with chylopericardium, a rare case and mini-review.

Authors:  Xuming Luo; Zhuhua Zhang; ShiQiang Wang; XianDong Gu; Xiongbiao Wang
Journal:  BMC Pulm Med       Date:  2018-01-29       Impact factor: 3.317

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.